Identifying and targeting proteins responsible for TRAIL resistance may also increase the anti-tumour potency of TRAIL, such as cFLIP (cellular FLICE-inhibitory protein) [66,67], cIAP1/cIAP2 [68] and XIAP [56,69,70]. The gene discussed is TNFSF10; the disease is neoplasm.